Open AccessRETRACTED ARTICLE:. WAYS TO IMPROVE TREATMENT EFFICIENCY OF PATIENTS WITH HIGH CARDIOVASCULAR RISK
Author(s) -
Г. А. Барышникова,
S A Chorbinskaya,
I. J. Stepanova
Publication year - 2015
Publication title -
evrazijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2305-0748
pISSN - 2225-1685
DOI - 10.38109/2225-1685-2015-3-62-66
Subject(s) - polypill , rosuvastatin , lisinopril , amlodipine , medicine , pill , intensive care medicine , pharmacology , aspirin , blood pressure , angiotensin converting enzyme
Retracted 11.11.2019 To reduce the overall cardiovascular risk it is advisable to use a combination of drugs - the poly-pill that will increase the effectiveness of therapy and patient compliance. The company «Gedeon Richter» has created a polypill - the Ekvamer medication, which in addition to amlodipine and lisinopril includes rosuvastatin - one of the most powerful and safe statins to date that will provide hosting and primary and secondary prevention of cardiovascular diseases and their complications.